2gz7: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease== | ==Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease== | ||
<StructureSection load='2gz7' size='340' side='right' caption='[[2gz7]], [[Resolution|resolution]] 1.86Å' scene=''> | <StructureSection load='2gz7' size='340' side='right'caption='[[2gz7]], [[Resolution|resolution]] 1.86Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2gz7]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Cvhsa Cvhsa]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GZ7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2GZ7 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2gz7]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Cvhsa Cvhsa]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GZ7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2GZ7 FirstGlance]. <br> | ||
Line 34: | Line 34: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Cvhsa]] | [[Category: Cvhsa]] | ||
[[Category: Large Structures]] | |||
[[Category: Lu, I L]] | [[Category: Lu, I L]] | ||
[[Category: Wu, S Y]] | [[Category: Wu, S Y]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Sars cov main protease]] | [[Category: Sars cov main protease]] |